Northside Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Northside Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.4M	Buy	32,741 +9,519	+41%	+$4.57M	1.34%	19
2026 Q1	$11.4M	Buy	23,222 +17,383	+298%	+$9.43M	1%	33
2025 Q4	$3.38M	Hold	5,839	–	–	0.29%	64
2025 Q3	$2.83M	Buy	5,839 +39	+0.7%	+$18.2K	0.26%	68
2025 Q2	$2.35M	Buy	5,800 +5,280	+1,015%	+$2.21M	0.18%	67
2025 Q1	$259K	Buy	520 +43	+9%	+$23.3K	0.04%	99
2024 Q4	$248K	Hold	477	–	–	0.07%	99
2024 Q3	$295K	Hold	477	–	–	0.05%	83
2024 Q2	$264K	Buy	477 +20	+4%	+$11.5K	0.05%	87
2024 Q1	$265K	Hold	457	–	–	0.05%	89
2023 Q4	$242K	Buy	457 +1	+0.2%	+$484	0.08%	93
2023 Q3	$231K	Hold	456	–	–	0.05%	91
2023 Q2	$238K	Hold	456	–	–	0.08%	85
2023 Q1	$263K	Sell	456 -49	-10%	-$27.6K	0.07%	78
2022 Q4	$278K	Buy	+505	New	+$268K	0.08%	73

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Northside Capital Management's TMO Position: Q2 2026 in Review

Northside Capital Management increased its Thermo Fisher Scientific (TMO) stake by 41% in Q2 2026, buying an estimated $4.57M and bringing the position to 32,741 shares worth $16.4M. The position accounts for 1.34% of the portfolio, ranked #19.

Northside Capital Management first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. 2,617 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Northside Capital Management held 32,741 shares of Thermo Fisher Scientific worth $16.4M as of Q2 2026.
Northside Capital Management bought 9,519 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.57M.
Thermo Fisher Scientific made up 1.34% of Northside Capital Management's portfolio in Q2 2026, its #19 holding.
Northside Capital Management first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Northside Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.